George F. Tidmarsh - 17 Apr 2023 Form 4 Insider Report for REVELATION BIOSCIENCES, INC. (REVB)

Role
Director
Signature
/s/ J.P. Galda, as attorney-in-fact for George F Tidmarsh
Issuer symbol
REVB
Transactions as of
17 Apr 2023
Net transactions value
+$59,740
Form type
4
Filing time
19 Apr 2023, 18:00:11 UTC
Previous filing
18 Apr 2023
Next filing
18 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REVB Common Stock Purchase $30,740 +26,500 +199% $1.16 39,848 17 Apr 2023 Direct F1
transaction REVB Common Stock Purchase $29,000 +25,000 +63% $1.16 64,848 18 Apr 2023 Direct
holding REVB Common Stock 43,525 17 Apr 2023 By Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted-average price at which shares were purchased within a range between $1.14 and $1.17. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F2 Shares are held by George Tidmarsh, Trustee George Francis Tidmarsh 2021 Irrevocable Trust with respect to which George Tidmarsh is a trustee.